Key facts
- Minetta Brook Capital is an investor with 3 tracked portfolio companies.
- Notable positions include OpenEvidence, Candid Therapeutics, LIS Technologies.
- Private Market View records 1 deal participation by Minetta Brook Capital.
- Minetta Brook Capital’s most recent recorded investment was in Mar 2026, one of 1 in the last 12 months.
Free account
See the whole book
- ·Every recorded deal — 1 rounds
- ·Watchlist + alerts for Minetta Brook Capital's activity
Create free account
No card required
Portfolio, priced
3 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| OpenEvidence | — | $12.0B | — | |
| Candid Therapeutics | Drug Discovery | $657.0M | — | |
| LIS Technologies | — | — | — |
Recent deals
1 recordedFrequently asked
- What companies does Minetta Brook Capital invest in?
- Minetta Brook Capital has 3 recorded portfolio companies, including OpenEvidence, Candid Therapeutics, LIS Technologies.
- Is Minetta Brook Capital actively investing?
- Minetta Brook Capital's most recent recorded investment was in Mar 2026, with 1 investments in the last 12 months.